Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Gilead Sciences Inc. (GILD)

-NasdaqGS
91.55 Down 2.24(2.39%) 4:00PM EDT
|After Hours : 91.45 Down 0.10 (0.11%) 7:49PM EDT - Nasdaq Real Time Price
Prev Close:93.79
Open:93.11
Bid:91.35 x 100
Ask:91.40 x 300
1y Target Est:109.86
Beta:1.01
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:91.25 - 93.37
52wk Range:55.96 - 94.34
Volume:13,432,053
Avg Vol (3m):11,661,800
Market Cap:139.71B
P/E (ttm):33.91
EPS (ttm):2.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 2.39%139.71B
GSKDown 0.21%116.18B
PFEDown 1.91%183.07B
RHHBYDown 1.36%246.82B

Key Statistics

Forward P/E (1 yr):10.09
P/S (ttm):8.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :7.67
Quarterly EPS Est (Sep-14) :1.82
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.45

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback